Category · Cosmetic peptides
Cosmetic peptides: small studies, big claims.
The peptides that show up in skincare lines — typically marketed as alternatives to retinoids, sunscreen, or Botox. The published human data is mostly small split-face trials, often manufacturer-funded. The grades reflect that.
Argireline (acetyl hexapeptide-8) is sold as a topical Botox alternative — it competitively inhibits the SNARE protein complex involved in muscle contraction. GHK-Cu is a copper-peptide complex with roles in wound healing and skin remodeling. Snap-8 (acetyl octapeptide-3) is a close argireline relative. All three have small human studies showing measurable but typically modest effects on fine lines or skin texture.
Note on the gap between cosmetic and pharmaceutical evidence: a "clinical study" cited on a skincare product label rarely meets the bar of a pharmaceutical RCT — small sample, no blinding, manufacturer-funded, looking for any effect rather than a pre-specified primary endpoint. Real but limited.
- 5/10 · Early Argireline Reducing the appearance of dynamic facial wrinkles (crow's feet, forehead and frown lines) when applied to the skin.
- 5/10 · Early GHK-Cu Wound healing, skin repair, collagen stimulation, anti-aging and hair-care cosmetics.
- 1/10 · Unsupported SNAP-8 Reducing the appearance of dynamic (expression) facial wrinkles when applied to the skin.
Reading this class honestly
Topical absorption is its own variable — these compounds work only if they actually penetrate skin in active form, and the formulation matters as much as the molecule. See how we grade and how to read a study for reading these split-face trials critically.